CVS.NEO CVS HEALTH CDR (CAD HEDGED)
- Market cap
- CAD 158B
- P/E
- 229.4x
- P/B
- 1.29x
- ROE
- 14.9%
- Dividend yield
- 3.46%
- Fundamental score
- 1.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CVS.NEO undervalued?
Graham numberThe Graham number of CVS HEALTH CDR (CAD HEDGED) cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CVS HEALTH CDR (CAD HEDGED) fundamental analysis
8 of 22 checks passedROE 1/2
Moderate return on equity (14.9%), between 10% and 20%.
ROA 1/1
Return on assets (4.7%) is above the industry median (2.7%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-62.0%) is below the industry median (1.4%).
Revenue Growth 1/2
Revenue grew 7.6% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (74.6%), up to 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 6.2x against interest expense, well covered.
PE vs Market 0/1
PE (240.0x) is above the market median (20.3x).
PE vs Industry 0/1
PE (240.0x) is above the industry median (22.9x).
PBV 1/1
Price to book (1.3x) is below the industry median (1.4x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 323.3, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (0.8%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
Payout ratio is 192.1%, above 90% of earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
CVS HEALTH CDR (CAD HEDGED) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CVS HEALTH CDR (CAD HEDGED)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health…
Full company profileCVS HEALTH CDR (CAD HEDGED) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CVS HEALTH CDR (CAD HEDGED) annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 322B | 358B | 373B | 402B | 413B |
| Gross Profit | 54.5B | 54.4B | 51.4B | 55.4B | 62.7B |
| Operating Income | 16.3B | 14.6B | 9.70B | 10.4B | 18.8B |
| EBITDA | 12.3B | 18.2B | 13.7B | 9.86B | 23.4B |
| Net Income | 4.31B | 8.34B | 4.61B | 1.77B | 11.8B |
| EPS | 3.32 | 6.48 | 3.66 | 1.39 | 9.27 |
| Balance Sheet | |||||
| Total Assets | 228B | 250B | 253B | 254B | 254B |
| Total Liabilities | 157B | 173B | 177B | 178B | 174B |
| Shareholders' Equity | 71.5B | 76.5B | 75.6B | 75.2B | 79.7B |
| Cash & Short-term Investments | 12.9B | 8.20B | 8.59B | 8.45B | 11.3B |
| Cash Flow | |||||
| Operating Cash Flow | 16.2B | 13.4B | 9.11B | 10.6B | 21.2B |
| Capital Expenditure | 2.73B | 3.03B | 2.78B | 2.83B | 3.08B |
| Free Cash Flow | 13.5B | 10.4B | 6.33B | 7.81B | 18.1B |
| Ratios | |||||
| ROE | 6.0% | 10.9% | 6.1% | 2.4% | 14.9% |
| ROA | 1.9% | 3.3% | 1.8% | 0.7% | 4.7% |
| Net Profit Margin | 1.3% | 2.3% | 1.2% | 0.4% | 2.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CVS HEALTH CDR (CAD HEDGED) dividends
- Dividend yield
- 3.46%
- Forward dividend
- 0.65 CAD
- Payout ratio
- 192.1%
- Ex-dividend date
- Oct 23, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 3.40B | 2.67 | 192.1% |
| 2024 | USD 3.37B | 2.68 | 73.1% |
| 2023 | USD 3.13B | 2.43 | 37.5% |
| 2022 | USD 2.91B | 2.24 | 67.4% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CVS HEALTH CDR (CAD HEDGED)
Ownership data of CVS HEALTH CDR (CAD HEDGED) is not available yet.
CVS HEALTH CDR (CAD HEDGED) company profile
- Company name
- CVS HEALTH CDR (CAD HEDGED)
- Ticker
- CVS.NEO
- Exchange
- NEO Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 219,000
- Fiscal year end
- December
- Address
- One CVS Drive, Woonsocket, RI, United States, 02895
- Phone
- 401 765 1500
- Website
- cvshealth.com
About CVS HEALTH CDR (CAD HEDGED)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
CVS HEALTH CDR (CAD HEDGED) management
10- Mr. Roger N. FarahExecutive Chairman of the Board · born 1953
- Mr. J. David Joyner CEBSPresident, CEO & Director · born 1965
- Mr. Tilak MandadiEVP of Ventures and Chief Experience & Technology Officer · born 1964
- Ms. Heidi B. CapozziExecutive VP & Chief People Officer · born 1970
- Mr. Prem S. Shah Pharm.DExecutive VP & Group President · born 1980
- Mr. Brian O. NewmanExecutive VP & CFO · born 1969
- Mr. James David ClarkSenior VP, Controller & Chief Accounting Officer · born 1965
- Mr. David A. FalkowskiExecutive VP & Chief Compliance Officer
- Mr. Samrat S. Khichi Esq.Executive VP, Chief Policy Officer & General Counsel · born 1967
- Mr. Gustavo A. GiraldoHead of Markets of Healthcare Benefits · born 1973